Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis).
about
Herbal medicine for management of the behavioural and psychological symptoms of dementia (BPSD): A systematic review and meta-analysis.Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia.Role of EphA4 signaling in the pathogenesis of amyotrophic lateral sclerosis and therapeutic potential of traditional Chinese medicine rhynchophylline.Effectiveness of Traditional Chinese Medicineas as an Adjunct Therapy for Refractory Schizophrenia: A Systematic Review and Meta Analysis.
P2860
Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Efficacy and safety of yokukan ...... Scale, five-factor analysis).
@en
Efficacy and safety of yokukan ...... Scale, five-factor analysis).
@nl
type
label
Efficacy and safety of yokukan ...... Scale, five-factor analysis).
@en
Efficacy and safety of yokukan ...... Scale, five-factor analysis).
@nl
prefLabel
Efficacy and safety of yokukan ...... Scale, five-factor analysis).
@en
Efficacy and safety of yokukan ...... Scale, five-factor analysis).
@nl
P2093
P2860
P1433
P1476
Efficacy and safety of yokukan ...... Scale, five-factor analysis).
@en
P2093
Haruo Seno
Jun Horiguchi
Kenta Murotani
Masaomi Iyo
Masaya Tohyama
Motohide Furuya
Norio Mori
Sachiko Ezoe
Sadayuki Hashioka
P2860
P2888
P304
P356
10.1007/S00213-014-3645-8
P577
2014-06-13T00:00:00Z